Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE American:PLX)

0.79
Delayed Data
As of Oct 20
 +0.009 / +1.15%
Today’s Change
0.26
Today|||52-Week Range
1.51
+77.53%
Year-to-Date

Today’s Trading

Previous close0.78
Today’s open0.81
Day’s range0.77 - 0.81
Volume1,232,074
Average volume (3 months)897,969
Market cap$105.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-251.54%
Earnings growth (this year)-17.24%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+110.79%
P/E ratioNM
Price/Sales4.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MTFBMotif Bio PLC+0.05+0.47%
NEPTNeptune Technologies...-0.01-1.17%
CODXCo-Diagnostics Inc+0.13+2.16%
AQBAquaBounty Technolog...-0.07-1.01%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$9.2M
Annual profit (last year)-$29.4M
Net profit margin-317.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Hazafon

Forecasts